Structure of Benazepril HCl
CAS No.: 86541-74-4
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Benazepril HCl is an ACE inhibitor, primarily used in treatment of hypertension. Benazepril HCl is the HCl form of Benazepril.
Synonyms: CGS14824A; Benazepril (hydrochloride); CGS 14824A HCl
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 86541-74-4 |
Formula : | C24H29ClN2O5 |
M.W : | 460.95 |
SMILES Code : | O=C(CN1C([C@H](CCC2=C1C=CC=C2)N[C@@H](CCC3=CC=CC=C3)C(OCC)=O)=O)O.[H]Cl |
Synonyms : |
CGS14824A; Benazepril (hydrochloride); CGS 14824A HCl
|
MDL No. : | MFCD00895734 |
InChI Key : | VPSRQEHTHIMDQM-FKLPMGAJSA-N |
Pubchem ID : | 5362123 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00000620 | Atherosclerosis ... More >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease Less << | Phase 3 | Completed | - | United States, Minnesota ... More >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada Less << |
NCT01076205 | - | Completed | - | - | |
NCT01669434 | - | Completed | - | - | |
NCT01715584 | Hypertension | Phase 4 | Recruiting | December 31, 2019 | Canada, Ontario ... More >> London Health Sciences Centre - Victoria Campus Recruiting London, Ontario, Canada, N6A 5W9 Contact: Craig J Railton, MD, PhD 519 685 8500 ext 58525 Craig.Railton@lhsc.on.ca Principal Investigator: Craig J Railton, MD, PhD Sub-Investigator: Jonathan Fairbairn, BSc Sub-Investigator: George Nicoloau, MD Sub-Investigator: Robert Gros, PhD Sub-Investigator: Jason Franklin, MD Sub-Investigator: John Yoo, MD Sub-Investigator: Kevin Fung, MD Sub-Investigator: Anthony Nichols, MD Sub-Investigator: Danielle McNeil, MD Less << |
NCT00170950 | Hypertension | Phase 3 | Terminated(The study was termi... More >>nated early because of significant efficacy results for the primary endpoint in favor of benazepril/amlodipine treatment.) Less << | - | United States, New Jersey ... More >> Novartis Pharmaceuticals E. Hanover, New Jersey, United States, 07936 Denmark sites in Denmark Denmark, Denmark Finland sites in Finland Finland, Finland Norway sites in Norway Norway, Norway Sweden sites in Sweden Sweden, Sweden Less << |
NCT01669434 | Hypotension on Induction | Phase 4 | Completed | - | United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less << |
NCT01867047 | Adverse Effects of Angiotensin... More >>-converting-enzyme Inhibitors Hypotension Less << | Not Applicable | Terminated(Following an interi... More >>m analysis the study team felt that there was enough data that showed no significant difference.) Less << | - | United States, North Carolina ... More >> Duke University Durham, North Carolina, United States, 27710 Less << |
NCT00170950 | - | Terminated(The study was termi... More >>nated early because of significant efficacy results for the primary endpoint in favor of benazepril/amlodipine treatment.) Less << | - | - | |
NCT01603940 | Hypertension ... More >>Diabetes Mellitus Less << | Phase 4 | Completed | - | Brazil ... More >> Hospital Universitario Pedro Ernesto Rio de Janeiro, RJ, Brazil, 20551030 Less << |
NCT00171119 | Hypertension ... More >>Diabetic Nephropathy Less << | Phase 4 | Terminated | - | Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less << |
NCT00000620 | - | Completed | - | - | |
NCT01867047 | - | Terminated(Following an interi... More >>m analysis the study team felt that there was enough data that showed no significant difference.) Less << | - | - | |
NCT00630708 | Renal Insufficiency, Chronic | Not Applicable | Terminated(Significant differe... More >>nces observed between groups.) Less << | - | China, Guangdong ... More >> Renal Division, Nanfang Hospital,Southern Medical University Guangzhou, Guangdong, China, 510515 Less << |
NCT01603940 | - | Completed | - | - | |
NCT02532777 | Henoch-Schoenlein Purpura Neph... More >>ritis Less << | Phase 2 | Recruiting | July 2020 | China, Jiangsu ... More >> Nanjing Children's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Aihua Zhang, M.D. +8618951769017 bszah@163.com Less << |
NCT01375322 | Hypertension ... More >>Diabetes Mellitus, Type 2 Albuminuria Less << | Phase 4 | Completed | - | Taiwan ... More >> Chang Gung Memorial Hospital-Kaohsiung Kaohsiung, Taiwan, 833 Taichung Veterans General Hospital Taichung, Taiwan, 407 Tri-Service General Hospital Taipei, Taiwan, 114 Far Eastern Memorial Hospital Taipei, Taiwan, 220 Less << |
NCT00367978 | Hypertension | Phase 4 | Completed | - | United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Less << |
NCT00907374 | Microalbuminuria | Not Applicable | Completed | - | United States, California ... More >> Charles Drew University Los Angeles, California, United States, 90059 Less << |
NCT00907374 | - | Completed | - | - | |
NCT02532790 | Henoch-Schoenlein Purpura Neph... More >>ritis Less << | Phase 2 | Recruiting | July 2020 | China, Jiangsu ... More >> Nanjing Children's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Aihua Zhang, M.D. +8618951769017 bszah@163.com Less << |
NCT01095939 | Renal Alteration | Phase 3 | Completed | - | Switzerland ... More >> Geneva University Hospitals Geneva, Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland Less << |
NCT03591471 | Henoch-Sch?nlein Purpura Nephr... More >>itis Less << | Phase 1 Phase 2 | Recruiting | December 2018 | China, Henan ... More >> Children's Hospital, The First Affiliated Hospital of HUTCM Recruiting Zhengzhou, Henan, China, 450000 Contact: Ying Ding, Director +86-13503840642 dingying3236@sina.com Contact: Xia Zhang, secretary +86-13838276039 zhangxia_125@163.com Principal Investigator: Ying Ding, Director The First Affiliated Hospital of Henan University of Traditional Chinese Medicine Recruiting Zhengzhou, Henan, China, 450000 Contact: Ying Ding, MD +86-371-66221361 dingying3236@sina.com Contact: Xia zhang, MD +86-371-13213210370 ardar123@sina.com Principal Investigator: Jiansheng Li, MD Less << |
NCT01234922 | Hypertension ... More >>Unspecified Adult Solid Tumor, Protocol Specific Less << | Phase 2 | Terminated(slow accrual) | - | United States, North Carolina ... More >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less << |
NCT00234871 | Hypertension ... More >>Diabetes Proteinuria Less << | Phase 4 | Completed | - | - |
NCT00136851 | Hypertension | Phase 4 | Completed | - | United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less << |
NCT00836576 | Healthy | Phase 1 | Completed | - | United States, Missouri ... More >> Gateway Medical Research, Inc. St. Charles, Missouri, United States, 63301 Less << |
NCT00649597 | Healthy | Phase 1 | Completed | - | United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less << |
NCT00649038 | Healthy | Phase 1 | Completed | - | United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less << |
NCT01234922 | - | Terminated(slow accrual) | - | - | |
NCT00649402 | Healhty | Phase 1 | Completed | - | United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less << |
NCT00778674 | Healthy | Not Applicable | Completed | - | United States, North Carolina ... More >> aaiPharma, Inc. Chapel Hill, North Carolina, United States, 27517 Less << |
NCT00836537 | Healthy | Phase 1 | Completed | - | United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less << |
NCT00834977 | Healthy | Phase 1 | Completed | - | Canada, Quebec ... More >> Anapharm Inc. Montreal, Quebec, Canada, H3X H29 SFBC Anapharm Sainte-Foy, Quebec, Canada, G1V 2K8 Less << |
NCT00649519 | Healthy | Phase 1 | Completed | - | United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less << |
NCT00835367 | Healthy | Phase 1 | Completed | - | Canada, Quebec ... More >> Anapharm Inc. Montreal, Quebec, Canada, H2X 2H9 SFBC Anapharm Sainte-Foy, Quebec, Canada, G1V 2K8 Less << |
NCT00835367 | - | Completed | - | - | |
NCT00834977 | - | Completed | - | - | |
NCT01155908 | Healthy | Phase 1 | Completed | - | - |
NCT01155895 | Healthy | Phase 1 | Completed | - | - |
NCT00778726 | Healthy | Not Applicable | Completed | - | United States, North Carolina ... More >> aaiPharma, Inc Chapel Hill, North Carolina, United States, 27517 Less << |
NCT01505998 | Fed | Phase 1 | Completed | - | India ... More >> Vimta Labs Ltd. Hyderabad, A.P, India, 500 051 Less << |
NCT01506011 | Fasting | Phase 1 | Completed | - | India ... More >> Vimta Labs Ltd. Hyderabad, A.P, India, 500 051 Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.17mL 0.43mL 0.22mL |
10.85mL 2.17mL 1.08mL |
21.69mL 4.34mL 2.17mL |
|
Dissolving Methods |
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
|
Tags: Benazepril HCl | CGS14824A | Cardiovascular System | Depressurization | Angiotensin Converting Enzyme Inhibitor | Carboxylic Acids | ACE | Organic Building Blocks | Classical Positive Drugs | Small Molecule Positive Drugs | Enzyme Inhibitors | Endocrinology/Hormones | 86541-74-4
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL